Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
13 janv. 2025 07h00 HE
|
Greenwich LifeSciences, Inc.
STAFFORD, Texas, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...